M-Cin 5 Tablets

babies: it is not applicable. lactation mother: consult your doctor because human studies have shown evidence of harmful effects on the baby. pregnancy: consult your doctor because animal and human studies have shown limited evidence of harmful effects on developing babies. driving: it is unsafe to use this medication as it may cause transient vision loss, drowsiness, dizziness, and light-headedness.
do not drive if these symptoms occur. alcohol: it is safe to consume alcohol because it does not show any harmful effects. kidney: safe if prescribed by your doctor in patients with kidney disease.
no dose adjustment is necessary. liver: this medication must be used with caution in patients with liver disease.
no dose adjustment is necessary for mild to moderate liver disease..

Nausea Dizziness Headache Diarrhea.

M CIN works by preventing the bacterial cells from dividing and repairing and thus kills the microorganisms..

If you miss a dose of M CIN, take it as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• inform your doctor if you experience blood in stools. • advice the patient to report the symptoms like pain in tendons, numbness, or tingling sensation.
• advice the patient to report the symptoms like allergic reactions, swelling of the face and mouth, or shortness of breath. • do not stop taking M CIN medication unless told by your doctor as it may cause worsen the condition..

contraindicated • moxifloxacin hydrochloride + pimozide: concurrent use of moxifloxacin hydrochloride and pimozide leads to an increase in qt interval. • moxifloxacin hydrochloride + quinidine: the concurrent use of moxifloxacin hydrochloride and quinidine increases qt interval. • moxifloxacin hydrochloride + strontium ranelate: concurrent use may lead to an increase in strontium ranelate levels by decreasing moxifloxacin hydrochloride. serious • moxifloxacin hydrochloride + amiodarone: concurrent use of moxifloxacin hydrochloride and amiodarone leads to increase qt interval. • moxifloxacin hydrochloride + arsenic trioxide: concurrent use of moxifloxacin hydrochloride and arsenic trioxide increases qt interval. • moxifloxacin hydrochloride + clarithromycin: concurrent use of moxifloxacin hydrochloride and clarithromycin leads to increase qt interval. monitor closely • moxifloxacin hydrochloride + azithromycin: concurrent use of moxifloxacin hydrochloride and azithromycin leads to increase qt interval. • moxifloxacin hydrochloride + dexamethasone: concurrent of moxifloxacin hydrochloride and dexamethasone leads to increase the risk of tendon rupture. minor • moxifloxacin hydrochloride + pyridoxine: concurrent use leads to an increase in moxifloxacin hydrochloride levels by decreasing pyridoxine.
• moxifloxacin hydrochloride + midazolam: concurrent use leads to an increase in midazolam levels by decreasing midazolam. .